SHINGLES

Clinical trials for SHINGLES explained in plain language.

Never miss a new study

Get alerted when new SHINGLES trials appear

Sign up with your email to follow new studies for SHINGLES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 3 Terminated 1

Pfizer's new shingles mRNA vaccine trial ends early

⭐️ VACCINE ⭐️ Terminated

This study tested a new mRNA vaccine to prevent shingles in healthy adults aged 50 to 85. Researchers checked for side effects and how well the vaccine triggered an immune response. The trial was stopped early, so results are limited.

Matched conditions: SHINGLES

Phase: PHASE1, PHASE2 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️

Last updated May 26, 2026 04:38 UTC

SHINGLES

Get alerted when new SHINGLES trials appear

Pfizer's new shingles mRNA vaccine trial ends early